Exam 4 - Endocrine Flashcards
(90 cards)
The ____ is the primary source of glucose production via glycogenolysis & gluconeogenesis
Liver
____ of the glucose released by the liver is freely metabolized by tissues in the brain, GI tract, and red blood cells
75%
After eating, when does glucose usage exceed availability?
2-4 hours
Glucagon plays a primary role in regulating blood glucose by?
- Stimulating glycogenolysis
- Simulating gluconeogenesis
- Inhibiting glycolysis
____ is the most common endocrine disease affecting ____ in 10 adults
Diabetes
1 in 10
What is Type 1a DM?
an autoimmune destruction of pancreatic β cells, leading to minimal or absentinsulin production
What is type 1b DM?
a rare, non-immune disease of absolute insulin deficiency
What is Type 2 DM?
- non-immune, and results from defects in insulin receptors and signaling pathways
- accounts for 90% of DM
What happens in Type 1 DM before onset of symptoms?
- A long period (9-13 yrs) of B-cell antigen production
- At least 80-90% B cell function is lost
Disease progression in Type 2 DM?
- In initial stages, tissues become desensitized to insulin, leading to ↑secretion
- Over time, pancreatic function decreases & insulin levels become inadequate
What 3 main abnormalities are seen in DM2?
- Impaired insulin secretion
- ↑hepatic glucose release c/b a reduction in insulin’s inhibitory effect on liver
- Insufficient glucose uptake in peripheral tissues
Causes of insulin resistance?
- Abnormal insulin molecules
- Circulating insulin antagonists
- Insulin receptor defects
Hgb A1c percentages for normal, prediabetic, and diabetic?
- Normal < 5.7%
- Prediabetic 5.7-6.4%
- Diabetic >6.5%
ADA criteria for diagnosis of diabetes?
- A1C > 6.5%
- FPG > 126 mg/dL
- 2 hr glucose > 200 mg/dL durting OGTT
- w symptoms of hyperglycemia - random glucose > 200 mg/dL
Initial treatment for DM2?
MOA?
- Metformin
- Enhances glucose transport into tissues
- ↓TGL & LDL levels
Sulfonylurea MOA?
- Simulates insulin secretion
- Enhances glucose transport to tissues
Sulfonylurea adverse effects?
- Sulfonylureas not effective long term d/t diabetic progressive loss of B cell function
- hypoglycemia, weight gain & cardiac effects
What treatments are most effective at lowering A1c?
Lifestyle changes, metformin, sulfonylureas: ↓ by 1-2%
Insulin: ↓ by 1.5-3.5%
GLP-1 antagonist: ↓ 0.5-1.5%
What drugs/substances can exacerbate hypoglycemia?
ETOH, metformin, sulfonylureas, ACE-I’s, MAOI’s, Non-selective BB’s
What is hypglycemia unawareness?
Treatment?
- Pt becomes desensitized to hypoglycemia and doesn’t show autonomic sx
- Neuroglycopenia ensues→fatigue, confusion, h/a, seizures, coma
- Tx: PO or IV glucose (may give SQ or IM if unconscious)
Onset, peak, and duration of the short acting insulins?
Onset, peak, and duration of the intermediate acting insulins?
Onset: 1-2 hours
Peak: 6-10 hours
Duration: 10-20 hours
Onset, peak, and duration for glargine (lantus)?
Onset: 1-2 hr
Peak: none
Duration: 24 hours
Patho of DKA?
- DKA more common in DM1, often triggered by infection/illness
- High glucose exceeds the threshold for renal reabsorption
- Creates osmotic diuresis & hypovolemia
- The liver overproduces of ketoacids